Allurion Technologies Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
137
- Stock Symbol
-
ALUR
- Investments
-
1
- Share Price
-
$2.32
- (As of Friday Closing)
Allurion Technologies General Information
Description
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Contact Information
Website
www.allurion.comCorporate Office
- 6 Boulevard Montmartre
- 75009 Paris
- France
Corporate Office
- 6 Boulevard Montmartre
- 75009 Paris
- France
Allurion Technologies Timeline
Allurion Technologies Stock Performance
As of 20-Jun-2025, Allurion Technologies’s stock price is $2.32. Its current market cap is $17.3M with 7.46M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.32 | $2.42 | $2.15 - $64.75 | $17.3M | 7.46M | 1.56M | -$11.16 |
Allurion Technologies Financials Summary
As of 31-Mar-2025, Allurion Technologies has a trailing 12-month revenue of $28.3M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 41,687 | 40,017 | 158,742 | |
| Revenue | 28,304 | 32,110 | 53,467 | 64,211 |
| EBITDA | (22,446) | (22,169) | (69,031) | (32,280) |
| Net Income | (24,355) | (26,148) | (80,607) | (37,744) |
| Total Assets | 38,414 | 32,813 | 71,712 | 51,370 |
| Total Debt | 32,975 | 37,923 | 41,857 | 59,531 |
Allurion Technologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Allurion Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Allurion Technologies Comparisons
Industry
Financing
Details
Allurion Technologies Competitors (1)
One of Allurion Technologies’s competitors is ReShape Lifesciences, a Formerly VC-backed company based in Eden Prairie, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ReShape Lifesciences | Formerly VC-backed | Eden Prairie, MN |
Allurion Technologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Allurion Technologies Patents
Allurion Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250009540-A1 | Balloon sealing and fill valve | Active | 12-Apr-2023 | ||
| US-12245962-B2 | Balloon sealing and fill valve | Active | 12-Apr-2023 | ||
| US-20250177177-A1 | Balloon sealing and fill valve | Pending | 12-Apr-2023 | ||
| EP-3886774-A1 | Enhanced fluid delivery system | Inactive | 13-Dec-2018 | ||
| EP-3886774-A4 | Enhanced fluid delivery system | Inactive | 13-Dec-2018 | A61F5/003 |
Allurion Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Allurion Technologies Acquisitions (1)
Allurion Technologies’s most recent deal was a Merger/Acquisition with Compute Health Acquisition. The deal was made on 01-Aug-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Compute Health Acquisition | 01-Aug-2023 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Allurion Technologies FAQs
-
When was Allurion Technologies founded?
Allurion Technologies was founded in 2009.
-
Where is Allurion Technologies headquartered?
Allurion Technologies is headquartered in Paris, France.
-
What is the size of Allurion Technologies?
Allurion Technologies has 137 total employees.
-
What industry is Allurion Technologies in?
Allurion Technologies’s primary industry is Therapeutic Devices.
-
Is Allurion Technologies a private or public company?
Allurion Technologies is a Public company.
-
What is Allurion Technologies’s stock symbol?
The ticker symbol for Allurion Technologies is ALUR.
-
What is the current stock price of Allurion Technologies?
As of 20-Jun-2025 the stock price of Allurion Technologies is $2.32.
-
What is the current market cap of Allurion Technologies?
The current market capitalization of Allurion Technologies is $17.3M.
-
What is Allurion Technologies’s current revenue?
The trailing twelve month revenue for Allurion Technologies is $28.3M.
-
Who are Allurion Technologies’s competitors?
ReShape Lifesciences is a competitor of Allurion Technologies.
-
What is Allurion Technologies’s annual earnings per share (EPS)?
Allurion Technologies’s EPS for 12 months was -$11.16.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
